Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive InfectionIn Vivo

dc.contributor.authorSecor, Patrick R.
dc.contributor.authorMichaels, Lia A.
dc.contributor.authorSmigiel, Kate S.
dc.contributor.authorRohani, Maryam G.
dc.contributor.authorJennings, Laura K.
dc.contributor.authorHisert, Katherine B.
dc.contributor.authorArrigoni, Allison
dc.contributor.authorBraun, Kathleen R.
dc.contributor.authorBirkland, Timothy P.
dc.contributor.authorLai, Ying
dc.contributor.authorHallstrand, Teal S.
dc.contributor.authorBollyky, Paul L.
dc.contributor.authorSingh, Pradeep K.
dc.contributor.authorParks, William C.
dc.date.accessioned2024-10-15T19:26:58Z
dc.date.issued2017-01
dc.description.abstractPseudomonas aeruginosa is an important opportunistic human pathogen that lives in biofilm-like cell aggregates at sites of chronic infection, such as those that occur in the lungs of patients with cystic fibrosis and nonhealing ulcers. During growth in a biofilm, P. aeruginosa dramatically increases the production of filamentous Pf bacteriophage (Pf phage). Previous work indicated that when in vivo Pf phage production was inhibited, P. aeruginosa was less virulent. However, it is not clear how the production of abundant quantities of Pf phage similar to those produced by biofilms under in vitro conditions affects pathogenesis. Here, using a murine pneumonia model, we show that the production of biofilm-relevant amounts of Pf phage prevents the dissemination of P. aeruginosa from the lung. Furthermore, filamentous phage promoted bacterial adhesion to mucin and inhibited bacterial invasion of airway epithelial cultures, suggesting that Pf phage traps P. aeruginosa within the lung. The in vivo production of Pf phage was also associated with reduced lung injury, reduced neutrophil recruitment, and lower cytokine levels. Additionally, when producing Pf phage, P. aeruginosa was less prone to phagocytosis by macrophages than bacteria not producing Pf phage. Collectively, these data suggest that filamentous Pf phage alters the progression of the inflammatory response and promotes phenotypes typically associated with chronic infection.
dc.identifier.citationSecor PR, Michaels LASmigiel KS, Rohani MG, Jennings LK, Hisert KBArrigoni A, Braun KR, Birkland TP, Lai Y, Hallstrand TS, Bollyky PL, Singh PK, Parks WC.2017.Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive Infection In Vivo. Infect Immun85:10.1128/iai.00648-16.https://doi.org/10.1128/iai.00648-16
dc.identifier.doi10.1128/iai.00648-16
dc.identifier.issn0019-9567
dc.identifier.urihttps://scholarworks.montana.edu/handle/1/18866
dc.language.isoen_US
dc.publisherAmerican Society for Microbiology
dc.rightsCopyright © American Society for Microbiology, [Filamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive InfectionIn Vivo. Infection and Immunity 85, 1 (2017)], Find the version of record at https://doi.org/10.1128/iai.00648-16
dc.rights.urihttps://perma.cc/D48E-G6MY
dc.subjectPseudomonas aeruginosa
dc.subjectbacteriophages
dc.subjectcystic fibrosis
dc.subjectdissemination
dc.subjectinflammation
dc.subjectlung infection
dc.subjectmacrophages
dc.subjectneutrophils
dc.titleFilamentous Bacteriophage Produced by Pseudomonas aeruginosa Alters the Inflammatory Response and Promotes Noninvasive InfectionIn Vivo
dc.typeArticle
mus.citation.extentfirstpage1
mus.citation.extentlastpage11
mus.citation.issue1
mus.citation.journaltitleInfection and Immunity
mus.citation.volume85
mus.relation.collegeCollege of Agriculture
mus.relation.departmentMicrobiology & Cell Biology
mus.relation.universityMontana State University - Bozeman

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
secor-noninvasive-infection-in-vivo-2017.pdf
Size:
992.88 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
825 B
Format:
Item-specific license agreed upon to submission
Description:
Copyright (c) 2002-2022, LYRASIS. All rights reserved.